Anticoagulants for Cardioembolism Prevention in Atrial Fibrillation Patients: Potential Bias From Real-World Studies
- PMID: 30442302
- DOI: 10.1016/j.jacc.2018.07.104
Anticoagulants for Cardioembolism Prevention in Atrial Fibrillation Patients: Potential Bias From Real-World Studies
Comment in
-
Reply: Anticoagulants for Cardioembolism Prevention in Atrial Fibrillation Patients: Potential Bias From Real-World Studies.J Am Coll Cardiol. 2018 Nov 13;72(20):2546-2547. doi: 10.1016/j.jacc.2018.09.024. J Am Coll Cardiol. 2018. PMID: 30442303 No abstract available.
Comment on
-
Global Prospective Safety Analysis of Rivaroxaban.J Am Coll Cardiol. 2018 Jul 10;72(2):141-153. doi: 10.1016/j.jacc.2018.04.058. J Am Coll Cardiol. 2018. PMID: 29976287
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical